AMAG Pharmaceuticals reviews fourth-quarter 2009 net item revenues of $12.

AMAG Pharmaceuticals reviews fourth-quarter 2009 net item revenues of $12 generic name for zithromax .8M due to Feraheme AMAG Pharmaceuticals, Inc. , a biopharmaceutical business focused on the commercialization and advancement of a therapeutic iron substance to treat iron deficiency anemia and novel imaging brokers to aid in the analysis of cancer and cardiovascular disease, today reported unaudited consolidated financial outcomes for the fourth year and quarter ended December 31, 2009.8 million, including $1.3 million of the $11.5 million in previously deferred product revenues.

‘For decades, AMGA members have been leaders in the use of care coordination and evidence-centered, team-based medicine, which will be the core components of accountable care. Our associates are distinguished to be innovative and offering patient-centered medical care,’ said Donald W. Fisher, PhD, CAE, president and chief executive officer of AMGA. ‘AMGA and its own members will continue steadily to focus on initiatives to deliver the right care at the right time for patients, in the most cost-effective manner available currently.’ By way of background, AMGA provides been instrumental in the development and advancement of industrial and federal accountable care organizations , in addition to lobbying aggressively for the provision’s inclusion in both the ACA and the Republican alternatives.